|
20 Mar 2008 |
CHMP Upholds Negative Opinion for the EU Application for Cimzia® in the Treatment of Crohn's Disease
|
|
20 Mar 2008 |
Seattle Genetics Initiates SGN-33 Clinical Trial in Combination with Revlimid(R) for Myelodysplastic Syndromes (MDS)
|
|
20 Mar 2008 |
Zevalin(R) Receives Positive CHMP Opinion in Europe for First-Line Consolidation Treatment
|
|
19 Mar 2008 |
MedImmune Advances Clinical Development of Antibody Targeting Interleukin-9 in Patients with Asthma
|
|
18 Mar 2008 |
Centocor, Inc. and Schering-Plough Submit Application Requesting Approval of Golimumab in Europe for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
|
|
17 Mar 2008 |
Amgen and Wyeth Announce Updates to U.S. Prescribing Information for Enbrel(R)
|
|
17 Mar 2008 |
MorphoSys Obtains Agreement for Production of Antibody Material in MOR202 Program with Crucell and DSM
|
|
16 Mar 2008 |
GlaxoSmithKline's Bosatria shows promise in late-stage study
|
|
13 Mar 2008 |
Raven Announces Initiation of a RAV12 Phase 2 Clinical Trial in Metastatic Pancreatic Cancer
|
|
13 Mar 2008 |
BioInvent signs deal with Bayer HealthCare for the discovery and development of therapeutic antibodies
|
|
12 Mar 2008 |
Amgen Statement on Successful Outcome of Romiplostim Panel Meeting
|
|
12 Mar 2008 |
Peregrine Pharmaceuticals Announces Positive Data From Cotara(R) Brain Cancer Trials
|
|
10 Mar 2008 |
iCo Therapeutics Provides iCo-008 Phase II Clinical Update
|
|
05 Mar 2008 |
Phase I/II Studies of IMC-A12 in Pediatric Cancer Patients Commence Enrollment
|
|
05 Mar 2008 |
Kyowa Hakko and Amgen Enter Licensing Agreement for Anti-CCR4 Humanized Monoclonal Antibody
|
|
04 Mar 2008 |
UCB: Early Data on Cimzia(R) from the WELCOME Study Show Efficacy in Infliximab-Refractory Crohn's Disease Patients
|
|
04 Mar 2008 |
Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application for XYOTAX(TM)
|
|
03 Mar 2008 |
BioWa Announces Expansion of License Agreement With Genetech for BioWa's POTELLIGENT(R) Technology
|
|
03 Mar 2008 |
Genmab and Pepscan to Identify Human Antibodies Against Intractable Targets
|
|
29 Feb 2008 |
Herceptin approved in Japan for early treatment in patients with HER2-positive breast cancer
|
|
27 Feb 2008 |
MorphoSys and Sigma-Aldrich Enter into a Collaboration and Licensing Agreement for Recombinant Research Antibodies
|
|
27 Feb 2008 |
FDA Approves Regeneron's ARCALYST(TM) (rilonacept) for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)
|
|
26 Feb 2008 |
Bradmer announces phase ii results published in newly diagnosed Glioblastoma which demonstrate improved survival and support upcoming Phase III study
|
|
25 Feb 2008 |
ESBATech's Antibody Fragments Demonstrate Penetration into the Eye with Topical Delivery Via Eye Drops
|
|
22 Feb 2008 |
FDA Grants Accelerated Approval of Avastin in Combination With Paclitaxel Chemotherapy for First-Line Treatment of Advanced HER2-Negative Breast Cancer
|
